Krsnaa Diagnostics Holds 15th Annual General Meeting on 25 September 2025
The announcement concerns routine AGM proceedings, including the adoption of financial statements, dividend declaration (without specifying amount), and re-appointment of directors, which are standard corporate governance activities and typically do not have a significant immediate impact on the company's stock price or operational outlook.
The announcement is a procedural report on the Annual General Meeting, detailing the attendees, presentations, and resolutions proposed without providing specific financial outcomes or contentious issues. This indicates a neutral stance.
* Krsnaa Diagnostics Limited held its 15th Annual General Meeting (AGM) on Thursday, September 25, 2025, via Video Conferencing (VC) / Other Audio-Visual Means (OAVM). * The meeting commenced at 11:00 Hrs. (IST) and concluded at 11:48 Hrs. (IST). * Mr. Rajendra Mutha, Chairperson and Whole Time Director, chaired the meeting, which saw the participation of 38 members, along with other Directors, Key Managerial Personnel (KMPs), Statutory Auditors, and the Secretarial Auditor. * Mr. Yash Mutha, Managing Director, and Ms. Pallavi Bhatevara, Whole Time Director, presented highlights on the company's financials, business performance, future endeavours, and Corporate Social Responsibility (CSR) initiatives. * The AGM considered and approved several resolutions, including: * Adoption of the Financial Statements for the financial year ended March 31, 2025. * Declaration of Final Dividend. * Re-appointment of Ms. Pallavi Bhatevara as a Director liable to retire by rotation. * Ratification of Remuneration payable to the Cost Auditors for the Financial Year 2025-26. * Approval for the continuation of Directorship of Mr. Chetan Desai as a Non-executive Independent Director post attaining the age of 75 Years (Special Resolution). * Appointment of M/s Dinesh Birla & Associates as Secretarial Auditor of the Company. * Remote e-voting for the resolutions was open from Monday, September 22, 2025, to Wednesday, September 24, 2025. An additional 15 minutes were provided for e-voting at the conclusion of the meeting. * Two registered speaker shareholders participated in the AGM.
What to do with a filing like this
Krsnaa Diagnostics Limited filed this with the NSE as a statutory disclosure, categorised under agm-egm. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Krsnaa Diagnostics Limited. Read the original for the full detail.